Mensdom Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 127.15%
- Profit Growth 108.82%
- Ebitda -198.57%
- Net Worth 3.57%
- Total Assets 20.19%
About Mensdom Pharmaceutical
Mensdom Pharmaceutical Private Limited (MPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 16 November 2019 (Five years and three months 9 days old ). Its registered office is in Jabalpur, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sulakshna Shahwal, Rajesh Shahu, and Kamlesh Shahu serve as directors at the Company.
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U52601MP2019PTC050108
- Company No.
050108
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Mensdom Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sulakshna Shahwal  | Director | 04-Apr-2024 | Current |
| Rajesh Shahu | Director | 08-Mar-2024 | Current |
| Kamlesh Shahu | Director | 16-Nov-2019 | Current |
Financial Performance of Mensdom Pharmaceutical.
Mensdom Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 127.15% increase. The company also saw a substantial improvement in profitability, with a 108.82% increase in profit. The company's net worth moved up by a moderate rise of 3.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mensdom Pharmaceutical?
Unlock access to Mensdom Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Syndikem Biopharma Private LimitedRajesh Shahu and Kamlesh Shahu are mutual person
- Aegrotat Pharmaceutical Private Limited
Kamlesh Shahu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mensdom Pharmaceutical?
Unlock and access historical data on people associated with Mensdom Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mensdom Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mensdom Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
